Ratner_Story_Live Like Lola_06

Childhood cancer receives 4% of U.S. federal funding for cancer research and only 1% of this goes to DIPG. Lola is the first patient to qualify for Phase I of the clinical trial at St. Jude. The goal is to find if the child can withstand the side effects under the highest possible dose. December 16, 2016.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s